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Abstract 
Purpose: For young women who were diagnosed with cancer prior to having children, reproductive 
potential might affect quality of life (QoL). This systematic review looks at fertility issues in young 
female cancer patients, focusing on their influence on psychological well-being, specific fertility-related 
interventions and reproductive decisions.  
Methods: Thirteen medical and social science databases were searched for relevant articles up to 
December 2012, according to PRISMA guidelines. Twenty-six articles meeting the eligibility criteria 
were included in the review, along with 5 additional papers that missed the inclusion criteria narrowly. 
Narrative synthesis was used to analyse the studies.  
Results: Depression, anxiety, and QoL seemed to be related to the perceptions of reproductive issues 
rather than to the fertility status based on the type of treatment received. Fertility-related interventions 
improved patients’ QoL, decisional regret, and decisional conflict. Finally, cancer influenced women’s 
reproductive decisions. Pursuing pregnancy was affected mainly by worries about child’s and mother’s 
health. Decisions about treatment were influenced by the wish to preserve fertility. The generalisability 
of these results might be undermined by small sample sizes and homogeneity of participants within and 
across the studies. Inferences about causality of associations are problematic due to predominantly cross-
sectional design.  
Implications for cancer survivors: The existing literature gives preliminary insight into the importance of 
fertility for young women diagnosed with cancer. However, more research is needed in order to offer 
patients comprehensive care. 
Keywords: cancer; fertility; parenthood; women; review; decision  
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Introduction 
The development of screening programmes and progress in cancer treatment have led to significant 
increase in cancer survival rates [1]. Given the comprehensive cancer treatment regimens involved, improving 
cancer patients’ quality of life is an important challenge for clinicians. Evidence shows that for young women 
with a diagnosis of cancer, being able to build a family and have children may be an important and cherished 
life goal determining their quality of life after the end of treatment [2, 3]. The qualitative evidence also suggests 
that being able to have children gives these women back their sense of normality, reconnects them with peers, 
and gives them additional motivation to survive the cancer diagnosis and treatment [2-6]. Since the age at first 
birth tends to increase [7], some women are diagnosed with cancer before they have had enough time to 
complete their families. Unsurprisingly, many of them step into the survivorship phase that is shadowed by 
reproductive concerns which can arise due to treatment resulting in sterility or the uncertainty regarding fertility 
status.  
Treatment modalities for the most commonly diagnosed cancers (breast, cervical, and ovarian) but also 
other, less frequent malignancies are known to influence women’s reproductive potential. For instance, the first 
line treatment for most of gynecological cancers but also other types of cancers located in the lower pelvis is 
surgery during which, depending on the stage of the disease, part or all of the reproductive organs are removed. 
This can lead to inability to bear biological children if hysterectomy or bilateral oophorectomy is performed. 
Total body irradiation (TBI) and pelvic irradiation may result in ovarian failure and damage to the uterine 
musculature and vascular system. Cranial irradiation can alter the functioning of hypothalamic-pituitary-gonadal 
axis resulting in reduced serum levels of sex-steroids and hence amenorrhea [8]. The negative effect of systemic 
chemotherapy (a standard treatment for young women with breast cancer) on reproductive function is widely 
acknowledged and depends on the age of the patient at drug administration, drug dosage, duration of therapy, 
and type of medications used [8, 9]. Chemotherapy is known to diminish the ovarian reserve which may result 
in an early-onset menopause even in women who continue menstruating after having received systemic 
treatment [10]. Hormonal therapy employed in hormone-positive breast cancer has been shown to increase the 
risk of amenorrhea in cancer survivors [11]. Moreover tamoxifen, the most commonly prescribed drug is 
considered to be a teratogen, meaning that pregnancy should be contraindicated during the time of therapy [12, 
13]. According to the guidelines, tamoxifen should be continued for five years after diagnosis [14]; therefore, 
for some patients with an already reduced ovarian reserve due to adjuvant chemotherapy, a window for 
childbearing would be very short. 
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In 2006, for the first time, the American Society of Clinical Oncology issued guidelines concerning 
fertility preservation in young people affected by cancer [15]. These, as well as the reviewed version of the 
guidelines [16] recommend that all clinicians discuss the possibility that cancer treatment may result in 
infertility at the earliest opportunity with all the patients. For patients interested in looking into their fertility 
options, early referral to a fertility specialist is advised. Specific recommendations for procedures available for 
children, adult males and adult females were added to the reviewed version of the guidelines [16]. However, not 
all patients can undergo these recommended procedures. Some women might be ineligible for a conservative 
gynaecologic surgery due to the advanced stage of disease at diagnosis and others might feel overwhelmed 
having to make a fertility preservation decision in a very short time between cancer diagnosis and the onset of 
treatment [17]. 
Additionally, some women may fear cancer recurrence due to fertility preservation [18] or may not 
have the financial resources to afford it. Finally, some young patients do not recall having had a conversation 
about the impact of cancer treatment on fertility with their treating physicians [19, 20] which prevents them 
from making an informed decision about their fertility.  
Even though discussing the effects that treatment might have on reproductive potential is a sensitive 
topic, the evidence shows that young women with cancer want information concerning fertility issues. 
According to Thewes et al. [13] women with breast cancer considered the provision of fertility-related 
information to be important at three time points: the time of diagnosis, treatment decision-making, and post-
treatment follow-up. In a web-based survey by Partridge et al. [21], 57% of breast cancer patients identified 
fertility concerns as a major issue at the time of their diagnosis. Qualitative data also indicate that some women 
are willing to alter the course of their cancer treatment [6] or forgo some part of treatment in order to preserve 
fertility [22].  
Fertility is an important concern for young female cancer patients and several reviews tackling 
different aspects of this issue have been published over the last few years [23-27]. These articles contribute to 
our understanding of what fertility and parenthood mean to cancer patients [24] and how its meaning can change 
over cancer trajectory [23]. They also examine knowledge [25] and information needs of patients [27] and when 
it is appropriate to discuss fertility [25]. The majority, however, [23, 24, 26, 27], only concentrate on breast 
cancer patients and although breast cancer is the most frequently diagnosed cancer in younger women, other 
cancers also occur in this group of patients and their treatment can equally affect patients’ fertility. One paper 
that describes how fertility issues are related to the quality of life [26] is not specific to cancer population and 
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includes women with all types of non-communicable health conditions (e. g. cystic fibrosis, diabetes, epilepsy, 
PCOS). Although these different diseases can all affect fertility, the psychological burden might be different for 
a life-threatening disease such as cancer as compared to the other conditions included in the review. Finally, 
Goncalves et al. [24] discuss reproductive decisions in breast cancer patients only, focusing on survivors’ 
attitudes and decisions towards pregnancy as well as risks and benefits of becoming a parent after cancer. Yet, 
this review did not include fertility preservation which constitutes one of the reproductive decisions that patients 
with cancer increasingly face. 
Therefore, in this review we will address the gaps still present in the literature. First of all, we will 
delineate a relationship between fertility issues and psychological well-being of reproductive age women 
diagnosed with cancer while making a distinction between their objective fertility status and their subjective 
perception of reproductive concerns (Objective 1). We will also address the impact of fertility-specific 
interventions on young female cancer patients’ psychological well-being (Objective 2). Finally, we will 
summarise the evidence on how cancer may affect reproductive decisions in young women with cancer, 
extending the definition of reproductive decisions beyond pregnancy post-cancer to treatment-related decisions 
that may affect fertility and also fertility preservation (Objective 3). This review will concentrate on all types of 
cancer diagnosed in women the treatment of which can potentially affect fertility. 
For the purpose of this review, several terms needed clarification.  Cancer treatment-related fertility 
issues were defined as both objective (e.g., surgery involving reproductive organs or chemotherapy) and 
subjective (e.g., self-assessed problems with conceiving or the reproductive concerns score as commonly 
measured by the Reproductive Concerns Scale [28]) as indicators of reproductive problems. Fertility-related 
interventions were operationalised as any type of intervention to promote fertility-related knowledge post-cancer 
diagnosis or provide psychosocial assistance (e.g., counselling by oncologists or fertility specialists, provision of 
decision aids and online support). Reproductive decisions were conceptualised as any decision that might relate 
to preserving the possibility of having children after cancer or actual decisions about childbearing post-cancer. 
Methods 
Search strategy 
This systematic review was conducted according to the PRISMA guidelines (see Online Resource 1, 
Table 1). The search for relevant articles was performed using the following medical and social science search 
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engines: NCBI (PubMed), OVID (Medline and Embase), Web of Science (Science Citation Index Expanded, 
Social Sciences Citation Index, Art&Humanities Citation Index, Conference Proceedings Citation Index – 
Science and Conference Proceedings Citation Index - Social Sciences & Humanities), PROQUEST 
(PsycArticles, Applied Social Sciences Index & Abstracts) and COCHRANE (Cochrane systematic reviews, 
Cochrane controlled trials and Cochrane methodological register). All databases were searched up to December 
2012 using the keywords presented in Table 2.  
Table 1. Search terms 
Column 1 Column 2 Column 3 Column 4 
‘woman’ ‘cancer OR tumor 
OR neoplasm OR 
malignancy’ 
‘fertility OR sterility 
OR reproduction OR 
childbearing OR 
pregnancy’ 
‘psychology OR distress OR depression OR 
anxiety OR fear OR PTSD OR quality of life OR 
self-esteem OR sexual OR recurrence OR 
reproductive decision OR decision making OR 
intervention OR counseling OR communication’ 
Inclusion criteria 
Population 
We included studies in which the study sample, at least in part, consisted of women diagnosed with 
various types of cancers (excluding childhood cancers and cancer diagnosed in the context of pregnancy) during 
their reproductive years. Being of reproductive age was defined as: (1) being premenopausal at the time of 
diagnosis or (2) being between 14 and 50 years of age at the time of diagnosis. The age range was selected 
based on the mean age at menarche and menopause worldwide [29]. If the study sample included women of all 
ages, it was eligible to be included only if the results for our target group were presented separately. In the case 
of studies including both men and women, only those presenting results separately for each gender and also our 
target age group were deemed eligible for inclusion. Studies that looked at women with various cancer 
diagnoses including cancers co-occurring with pregnancy or childhood cancers were only included if the results 
for our target group were presented separately. 
Outcomes 
Studies were included in the review if they measured the following outcomes for respective questions. 
For Objective 1: Anxiety; Depression; Quality of life; Sexual functioning; Worries about future 
conception/pregnancy 
For Objective 2: Anxiety; Depression; Quality of life; Decisional conflict; Decisional regret 
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For Objective 3: No pre-specified outcomes were selected for this question due to diversity of possible 
significant outcomes.  
Study design 
Quantitative experimental, quasi-experimental, and observational studies (cohort and case control 
studies) were included in the review. 
Exclusion criteria 
Studies were excluded if cancer diagnosis in the sample co-occurred with pregnancy (any cancer 
diagnosed in pregnant women or gestational trophoblastic disease); the focus of the study was on childhood 
cancers; combined results were presented for both genders, for women of all ages or for various cancers 
including childhood cancers and cancers diagnosed in the context of pregnancy. We also excluded papers that 
were written in non-English languages; the reviews, book chapters, commentaries, letters, guidelines, case 
studies and also the articles published before 1990, considering that the medical technology has changed 
substantially since then and new procedures allowing for the fertility sparing and preservation were established 
for female cancer patients [30]. Finally, we decided to exclude qualitative studies. We chose to do this since our 
search produced 44 qualitative articles potentially relevant based on title or abstract (8% of all the articles 
judged relevant by title) and these articles merit a separate qualitative synthesis, which was outside the scope of 
this review. 
Data collection and analysis  
A total number of 8040 articles were identified through the databases search. Automatic and manual 
de-duplication narrowed the number to 6507 articles. The first reviewer (AS) visually screened all the titles and 
identified 552 as potentially relevant. These 552 records were then examined by two reviewers as follows: 
 The first reviewer extracted and read the abstracts of all the 552 articles; 56 of them were found to be 
potentially relevant. 
 The second reviewer (GO) screened the titles of the 552 articles and singled out 385 that seemed 
potentially relevant. Subsequently the second reviewer read 385 abstracts and found 126 of them 
suitable. 
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Both reviewers subsequently discussed the discrepancies between their choices and after excluding the 
abstracts that reported on medical outcomes only, did not mention fertility, or concentrated on childhood 
cancers, 81 articles were retained for full-text assessment. These articles were independently read in full by each 
reviewer and compared against the established inclusion and exclusion criteria. The first reviewer deemed 40 
articles suitable while the second reviewer found 31 articles to match the criteria. The discrepancies were again 
resolved by discussion. The first reviewer contacted the authors of the publications that needed clarification in 
order to be included or excluded. We kept 26 articles meeting all the predefined criteria to be included in the 
review. The decision was also made to retain and separately describe five additional papers that missed one of 
the criteria (age or type of diagnosis) narrowly (see Online Resource 1, Figure 1). This is because excluding 
them could have potentially biased the results given that these studies have only slightly deviated from the 
inclusion criteria. Study by Carter et al. [31] included patients with gestational trophoblastic disease which was 
one of the exclusion criteria; however, they constituted only 6% of the study sample (5/88) and thus were 
unlikely to significantly influence the results of the study. Similarly, in the studies that have not met the age 
criterion, the proportion of participants that were outside the predefined age brackets was minimal (6.4% and 
12.8% where it was possible to determine [32, 33]) (for further details see Online Resource 2, Table 6).  
In total, 31 papers describing 28 separate studies were included in the review (papers by Letourneau et 
al. [34] and Letourneau et al. [35]; Peate et al. [36] and Peate et al. [37]; and Carter et al. [38] and Carter et al. 
[39] referred to the same respective datasets). For details see Tables 3-6 in Online Resource 2. 
The following data from the articles were extracted by the first reviewer: authors; date; location of 
study; study aim; study sample (including cancer type, age at diagnosis, sample size); study design; definitions 
of fertility; outcomes (constructs and measures); results for outcomes of interest.  
Papers were also assessed for their quality using a checklist designed to examine and provide a quality 
score for quantitative studies employing various study designs [40]. The quality of 10 randomly selected articles 
was assessed by both reviewers. Where the discrepancies in scores occurred, they were discussed and the inter-
rater reliability analysis was performed to determine the consistency between the observers. Kappa scores 
ranged from 0.44 to 1 representing moderate to substantial inter-rater agreement [41]. Subsequently, the first 
reviewer rated the quality of the remaining 21 articles. All the quality scores provided in the summary tables 
(see Tables 3-6 in Online Resource 2) are those assigned by the first reviewer. The narrative synthesis was used 
to analyse and interpret the data. The heterogeneity of study designs and outcome measures prevented the meta-
analytic approach. 
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Results 
For the purpose of this review, the articles were organised according to the specific objective of the 
review they pertained to and further according to the outcomes they described. Since there were no predefined 
outcomes related to the third objective, studies falling into this category were classified in the following manner: 
 The first group included articles that examined reproductive decisions related to pregnancy after 
cancer. Within this category, we concentrated on actual attempts to conceive, the desire to have 
children pre- and post-treatment as well as factors affecting decisions to have children after cancer. 
These results are summarised in the section titled “Pregnancy-related decisions”.  
 The second group comprised of the studies that explored decisions related to treatment modalities that 
could enable future fertility after cancer (fertility-sparing surgery or fertility preservation techniques). 
These results are summarised in the section titled “Treatment-related decisions”.  
Impact of cancer treatment-related fertility issues in reproductive age women on their psychological 
well-being 
Worry about pregnancy 
Three studies examined worries about pregnancy after cancer. These worries included the ability to 
become pregnant after treatment for breast cancer [42], the success of conceiving after radical trachelectomy 
[43], and concerns about conception after radical trachelectomy [38, 43]. In one study, 43.1% of breast cancer 
patients worried whether they would be able to have a pregnancy after cancer, if they wished that [42]. When 
asked about the success at conceiving, cervical cancer patients who underwent radical trachelectomy assessed 
their chance to be between 55% and 60% over a 2-year follow-up post-surgery with no marked change during 
that time [43]. Concerns about conceiving in cervical cancer patients scheduled for fertility-sparing treatment 
ranged from 90% before treatment to 100% at six months post-surgery in one study [38] and from 88% at six 
months post-treatment to 73% at 24 months post-treatment in another study [43]. 
Depression and anxiety 
Four studies looked at the association between fertility issues and depressive symptoms. One study 
used Hospital Anxiety and Depression Scale to measure depressive symptoms [44] while the remaining three 
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used the Centre for Epidemiologic Studies-Depression scale [39, 45, 46]. The two studies that defined fertility 
issues using an objective measure of having undergone either fertility-sparing or radical treatment did not find 
significant difference in the level of depressive symptoms or anxiety between the two groups of patients 
(ovarian in Bisseling et al. [44] cervical in Carter et al. [39]). However, the latter study reported that the mean 
scores for depressive symptoms in both groups of patients, those who underwent radical trachelectomy as well 
as those treated with radical hysterectomy, were suggestive of depression before the onset of either treatment 
and remained in a subclinical range after treatment [39]. Another study by Carter et al. [45] examining the group 
of cervical cancer patients whose fertility was damaged due to treatment, reported that 40% of their sample met 
the criteria for depression as measured by CES-D. Finally Gorman et al. [46] examined the association between 
the amount of reproductive concerns and depressive symptoms in breast cancer patients and found a significant 
association between the two. However, we were not able to ascertain the strength of this relationship. 
Quality of life (QoL) 
Five studies assessed the relationship between fertility issues and QoL. Two of the studies used the 
Functional Assessment of Cancer Therapy scale (the Cervical or Trial Outcome Index version) [39, 47], the 
other two used the Medical Outcomes Scale SF-36 [48, 49], and one used the Medical Outcomes Scale SF-12 
[50]. Two studies that operationalised fertility issues in a more objective manner (radical versus fertility-sparing 
treatment or occurrence of prolonged amenorrhea) did not find significant association between QoL and fertility 
issues. There was no significant difference in terms of QoL between patients who underwent radical 
trachelectomy and those who had radical hysterectomy [39]. Neither did prolonged amenorrhea at 12 month 
post-chemotherapy predict the quality of life in breast cancer patients [47]. The third study that referred to the 
medical definition of infertility (primary, where a woman did not have any children or secondary, where a 
woman had children prior to cancer and could not have them after treatment) post-cancer found a significant 
difference in the Mental Component Summary score (MCS) (SF-12) between women who had the desired 
children and those who were infertile [50]. Two studies in which fertility issues were defined in a more 
subjective manner (self-reported inability to have children post-cancer or the level of reproductive concerns as 
measured by RCS [28]) showed a significant association between QoL and fertility issues. In a study by 
Mancini et al. [48], cancer patients with various diagnoses who considered themselves infertile had significantly 
lower both Mental and Physical Component Summary (PCS) scores (SF-36) compared to participants who did 
not report infertility. Wenzel et al. [49] examined cervical cancer patients and although they found no 
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differences in MCS and PCS between patients and healthy controls, better MCS scores among patients were 
significantly associated with fewer reproductive concerns. The latter were also significantly related to better 
survivor-specific QoL as measured by QoL-CS [49]. 
Sexual functioning 
Four studies reported on the relationship between fertility issues and sexual functioning. To assess 
sexual functioning, two of the studies used the Female Sexual Functioning Index (FSFI) [39, 50], one study used 
the Gynecologic Problems Checklist (GCP) as well as the Sexual Activity Questionnaire (SAQ) [49], and lastly 
one study used a single question assessing sexual functioning [48]. Carter et al. [39] who compared cancer 
patients who had undergone fertility-sparing surgery for cervical cancer to those who had had radical treatment 
found no differences between the groups in terms of sexual functioning. However, both groups scored in the 
range of sexual dysfunction with the scores stable over the 24-month follow-up period. The study by Wenzel et 
al. [49] where two instruments were used to assess sexual functioning delivered mixed results indicating no 
difference between infertile cancer patients and controls in sexual functioning as measured by GCP but a 
significant difference in sexual discomfort as measure by SAQ. In  Canada, Schover [50] study, patients with 
primary or secondary infertility post-cancer scored significantly lower on FSFI than women who had the desired 
children. In the same study, women who viewed themselves as infertile had lower sexual satisfaction that those 
who did not. Wenzel et al. [49] also indicated that higher reproductive concerns in survivors were significantly 
associated with poorer sexual functioning. Finally, Mancini et al. [48] found that patients who self-identified as 
infertile reported significantly more negative consequences of cancer and its treatment on sexual life that those 
patients who considered themselves fertile.  
Effect of fertility-related interventions delivered prior to cancer treatment on women’s psychological 
well-being 
Quality of life (QoL) 
Three studies explored the influence of fertility-related interventions for young female cancer survivors 
on their QoL [34, 51, 52]. Each study used a different QoL measurement tool which makes direct comparisons 
problematic. Letourneau et al. [34] compared young women diagnosed with various cancers who had been 
counselled about the possible impact of cancer treatment on their fertility to those who had not been counselled. 
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Women who remembered being counselled had statistically significantly better physical and psychological 
health scores as measured by WHOQOL-BREF questionnaire [53] than their non-counselled counterparts. The 
QoL as measured by Satisfaction With Life Scale (SWLS) [54] did not differ between the groups. Similarly, in 
the models predicting QoL outcomes, adjusted for age at diagnosis, parity before treatment and cancer site, 
counselling (as primary predictor) did not reach statistical significance. Letourneau et al. [34] also examined 
different types of counselling and compared (1) women who had only been counselled by an oncologist to those 
who had been counselled by both an oncologist and fertility specialist and (2) women who had only been 
counselled by an oncologist to those who had been counselled by an oncologist and additionally pursued fertility 
preservation (FP). In the first case, women who had been counselled by both an oncologist and a fertility 
specialist had significantly better QoL as measured by SWLS and also fared better in the physical health domain 
of WHOQOL-BREF compared to women who had only been counselled by an oncologist. Counselling by both 
specialists remained a significant predictor of physical health in a model adjusted as above. A similar pattern 
was found when comparing women who had been counselled by an oncologist and who decided to pursue FP to 
those who had only been counselled by an oncologist. In an adjusted model, however, counselling and pursuing 
FP significantly predicted QoL as measured by SWLS [34]. 
A study by Meneses et al. [51] studied the effect on an online intervention consisting of educational 
resources and the possibility to interact with other survivors and the researchers on the QoL of young breast 
cancer survivors. They noted statistically significant improvements in all the QoL domains (as measured by SF-
36 [55]) between baseline and follow-up at six months.  
Finally, Reh et al. [52] showed that among young cancer patients with various diagnoses referred to a 
fertility clinic, social domain of QoL as measured by FACT [56] improved over time in those who had 
undergone FP procedures, with other QoL scores remaining stable over time. 
Decisional regret 
Decisional regret was an outcome in two studies [34, 37]. Both used the Decision Regret Scale as a 
measurement tool [57] and referred to either a “decision to undergo (or not undergo) fertility preservation” [34] 
or “fertility treatment decisions” [37]. Letourneau et al. [34] found that decisional regret was significantly lower 
in cancer survivors who had undergone counselling by both an oncologist and a fertility specialist compared to 
those counselled only by an oncologist. The same pattern was found for women who had been counselled by an 
oncologist and decided to pursue FP when compared to those who had only been counselled by an oncologist. In 
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the models adjusted for age at diagnosis, parity before treatment and cancer site, counselling by oncologist and 
fertility specialist as well as counselling by oncologist and pursuing FP remained significant predictors of 
decisional regret. Peate et al. [37] studied the effect of a fertility-related decision aid (DA) compared to the usual 
care in breast cancer patients. They showed that women who received the DA did not significantly differ in 
decisional regret from women in the usual care at 1-month follow-up. The difference, however, reached 
significance at 12-month follow-up with women in the DA group having lower decisional regret. 
Decisional conflict 
Decisional conflict was measured as an outcome in one study using the Decisional Conflict Scale [37]. 
Young breast cancer survivors who received the DA experienced a greater reduction of the decisional conflict 
over 12 months than the patients in the usual care. The difference in the scores was not significant at 1-month 
follow-up but reached statistical significance at 12 months with the scores in the DA group 15.3 units lower on 
average than the scores in the usual care group. 
Depression and anxiety 
Peate et al. [37] also included depression and anxiety as outcomes in their study of the effect of the DA 
in a group of breast cancer patients. They found no significant differences in the change of either anxiety or 
depression as measured by HADS between the DA group and the usual care group over time. 
Impact of cancer diagnosis (from patient’s perspective) on reproductive decisions in reproductive age 
women and the possible psychological factors that might facilitate or hinder these decisions 
Pregnancy-related decisions 
Three studies looked at attempts to conceive post-cancer. In a study by Carter et al. [43] the number of 
cervical cancer survivors who had been treated with radical trachelectomy and who were trying to conceive 
post-treatment increased from 6% at 12-month follow-up to 21% at 24-month follow-up. Among breast-cancer 
survivors in a study conducted by Gorman et al. [46], 7% reported trying to become pregnant after cancer. 
Among ovarian cancer patients treated with conservative surgery, 49% attempted to conceive after treatment 
and out of these, 75% were successful [58]. 
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Eight studies explored the potential impact of cancer on the desire to have children. Huyghe et al. [59] 
and Gorman et al. [46] asked participants to rate their desire to have children pre- and post-diagnosis. In both 
studies, the numbers decreased from 43% to 29% and from 48% to 28%, respectively. Braun et al. [60] 
compared breast cancer survivors to healthy controls and found that the former desired significantly fewer 
children than the latter. Canada, Schover [50] and Zanagnolo et al. [58] assessed how cancer affected the desire 
to have children in a mixed cancer group and ovarian cancer patients, respectively. According to Canada, 
Schover [50] the desire to have children remained unchanged in 68% of patients, 17% reported that cancer 
decreased their desire to have children whereas 15% described the opposite trend. A similar tendency was 
reported by Zanagnolo et al. [58] with 78% of patients reporting that cancer had no impact on their desire to 
have children, and 7% and 5% respectively declaring a decrease and increase in their desire for children. 
Mancini et al. [48] and Patel et al. [61] only evaluated the desire to have children post-diagnosis and 
showed that 26.3% and 45% of participants wanted children after cancer, respectively. Finally, in a study by 
Atkinson et al. [62], 53.6% of reproductive age melanoma survivors thought that cancer would make them better 
parents.  
Eight studies examined potential factors affecting decisions related to pursuing pregnancy after cancer. 
A study by Braun et al. [60] showed that reported pros and cons of having children did not differ between breast 
cancer survivors and healthy controls; however, the remaining literature points to several factors influencing 
pregnancy-related decisions, specific for cancer survivors. These factors could generally be assigned to four 
categories: 1) child’s health and well-being; 2) fear of cancer recurrence; 3) pregnancy complications; 4) 
mother’s mental well-being. 
Child’s health and well-being  
Across studies, participants were concerned about possible birth defects or malformations due to cancer 
(3.6% of melanoma survivors in Atkinson et al. [62] and 15% of ovarian cancer patients in Zanagnolo et al. 
[58]) or its treatment (24% of participants in Zanagnolo et al. [58]), the risk of a child developing cancer (51.7% 
of melanoma survivors in Atkinson et al. [62]) and prematurely bereaving a child (6.7% of breast cancer 
survivors in a study by Rippy et al. [63]). Canada, Schover [50] also found that women who felt that cancer had 
interrupted their childbearing plans were more fearful of the effects that cancer could have on child’s health. 
Fear of cancer recurrence (FoR) 
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Fear of cancer recurrence as an explicit category was found to affect survivors’ decisions about 
pregnancy in three studies. It influenced reproductive decisions in 12.9% to 29% of patients ([62-64]. Avis et al. 
[42] reported that 48.3% of patients who were concerned about their fertility feared that pregnancy could affect 
the course of their disease. Additionally, Canada, Schover [50] found that women who felt that cancer had 
interfered with their childbearing plans were more worried that pregnancy could trigger cancer recurrence. 
Pregnancy complications 
Only Atkinson et al. [62] looked at concerns related to pregnancy complications due to cancer. In their 
sample of reproductive age melanoma survivors, 11.1% were bothered by the possibility that cancer might cause 
complications during pregnancy. 
Mother’s mental well-being 
Finally, one study studied how mental health could affect pregnancy rates post-breast cancer [65]. A 
trend towards better mental health (p=0.08) was reported for women who became mothers after diagnosis and 
treatment compared to survivors who did not have children after cancer. 
Treatment-related decisions 
Five studies looked at treatment-related decisions that could impact on survivors’ future childbearing. 
Two studies explored the decisions concerning fertility preservation [35, 36]. Among the three remaining 
studies each concentrated on a different treatment-related decision such as: the decision to undergo 
trachelectomy for cervical cancer [38, 39], the decision to undergo chemotherapy for breast cancer [21], and 
finally one study did not specify the type of treatment received by the participants [64]. 
Fertility concerns affected the decision about treatment in 29% of breast cancer survivors [21] and in 
13% of mixed female cancer group [64]. This was more of a case in women who wanted children, had prior 
difficulty conceiving, and recalled severe depression prior to diagnosis [21] as well as younger, unmarried 
women who had no successful pregnancies prior to cancer [64]. Additionally, Partridge et al. [21] analysed the 
kind of risks and benefits women were willing to accept given that chemotherapy could impair their fertility. 
Women who were more concerned about their reproductive potential required greater recurrence risk reduction 
and were less likely to accept higher risk of infertility due to chemotherapy compared to their less concerned 
counterparts.  
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Two publications from the same dataset by Carter et al. [38] and Carter et al. [39] examined patients’ 
reasons to undergo radical trachelectomy (RT). The most frequently cited reason was preservation of 
childbearing (97% of participants in the preliminary report [38] and 55% of participants in the final report [39]), 
followed by conversations with doctors (41% and 36% in the preliminary [38] and full report [39] respectively), 
family or future fertility options (41%, [38]), personal factors (28%, [38]) and research (17%, [39]). The full 
report [39] additionally examined the reasons for undergoing radical hysterectomy (RH) and found that 46% of 
patients decided upon this type of treatment following doctor’s recommendations, 25% because of concerns 
about survival and another 25% because they felt it was the best or the only available option. A significant 
difference between the RT and RH groups emerged, showing that 43% of patients in the RH group versus only 
7% of patients in the RT group had enough time to complete their families. 
Letourneau et al. [35] and Peate et al. [36] concentrated on fertility preservation among cancer 
survivors. The former study reported several factors associated with pursuing FP procedures, mainly: the age at 
diagnosis, desire for future children, the number of children at diagnosis, and education level. The latter study 
found that the intention to undergo FP was related to the importance women attached to fertility information and 
attitudes towards FP [36]. Additionally, women who had better knowledge about fertility issues related to cancer 
presented significantly lower decisional conflict concerning FP (less delay in making decision and less 
uncertainty about the implementation of the choice) than women who had less knowledge about the topic [36]. 
Additional articles 
Among the five articles that has just missed one of the inclusion criteria (age or type of diagnosis), two 
were related to the first objective of the review [31, 66], whereas 3 were related to the third objective [32, 33, 
67]. In general, the results from these studies were in line with the results from the studies that met all the 
inclusion criteria. 
The studies by Gershenson et al. [66] and Carter et al. [31] examined the impact of fertility issues on 
sexual functioning and depressive symptoms, respectively. Gershenson et al. [66] compared ovarian cancer 
patients who had undergone fertility sparing surgery to those who had had radical surgery and found that the 
latter group had a significantly greater sexual discomfort. Carter et al. [31] examined how distress caused by 
infertility secondary to cancer was associated with depressive symptoms in a sample of gynaecological cancer 
patients. They found that higher levels of distress were strongly related to depression as measured by CES-D.  
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Studies related to the third objective of this review all explored pregnancy-related decisions. In a study 
of a breast cancer population, Ganz et al. [32] found that 7% were attempting to conceive and 17% did manage 
to get pregnant post-cancer. Similarly, 18% of women reported getting pregnant post-diagnosis in a study of a 
mixed cancer population [67]. Ganz et al. [32] reported that the desire for children diminished, with 20% of 
women wanting children pre-diagnosis and only 11% post-diagnosis. However, in a study by Schover et al. [67], 
47% of women wanted pregnancy in the future. Sait [33] reported that 44% of the ovarian cancer participants 
claimed that cancer had not changed their desire to have children. Finally, the factors that could affect the 
decisions about pregnancy were child’s or mother’s health. 61% of ovarian cancer patients worried about the 
possible impact of their disease and treatment on offspring and 15% were anxious about complications or 
malformations in children [33].Risk of cancer recurrence and worry about pregnancy complications were 
mentioned by 17% and 13 % of participants respectively in a study by [67].   
Discussion 
The aim of the current review was to investigate fertility and parenthood issues experienced by young 
female cancer survivors.  
The first objective of this review was to synthesise the evidence for the impact of cancer treatment-
related fertility issues in reproductive age women on their psychological well-being. The findings suggest that 
fertility issues related to cancer treatment can indeed affect women’s psychological well-being; however, this 
depends both on the outcome of interest and also the definitions of fertility issues across the studies. 
Worries about pregnancy were present in both breast and cervical cancer survivors [38, 42, 43]. In the 
group of breast cancer patients this may be due to uncertainty about fertility status after chemotherapy since it is 
known to diminish fertility. Its effect depends on multiple factors (type of regimen, dose, and age of the patient) 
[8, 9] and even though methods exist to assess ovarian reserve in patients (and by proxy their fertility potential) 
these are not systematically used [8]. Therefore, patients cannot be sure about their reproductive potential, 
unless they get pregnant. Patients with cervical cancer treated with fertility sparing surgery might still worry 
about future pregnancy since this procedure is known to cause cervical stenosis (the narrowing of the cervical 
canal), scarring, and changes to the normal anatomy of the cervix which can all lead to infertility [68]. It can 
also result in pregnancy complications such as pregnancy loss or premature delivery [68, 69]. 
There was some evidence that depressive symptoms were present among gynaecological cancer 
patients [39, 45] but they did not seem to differ by treatment modality (fertility sparing versus radical surgery) 
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[39, 44]. However, self-reported distress or concerns related to fertility issues were associated with more 
depressive symptoms [31, 46]. A similar pattern emerged from the studies looking at QoL as an outcome. 
Where fertility issues were conceptualised objectively – as prolonged amenorrhea or radical treatment, they did 
not correlate with QoL [39, 47]. However, where self-report measures assessing reproductive potential were 
used, fertility issues were significantly related to QoL [48-50]. Holton et al. [25] systematic review of 
childbearing concerns and information needs of women with chronic non-communicable health conditions 
suggests that reproductive issues can influence the quality of life and add to depressive symptoms in this group 
of women, yet they do not make a distinction between the subjectively and objectively defined fertility issues. 
Studies examining sexual functioning delivered mixed results which depended to some extent on the 
measurement tool used [49]. Yet, similar to the findings on depressive symptoms and QoL, sexual functioning 
tended to be associated more with self-reported level of fertility concerns [48-50] than objectively defined 
infertility [39]. Nonetheless, patients, despite the treatment they had received, reported impaired sexual 
functioning [39]. 
These results may suggest that depressive mood and QoL of young women who were treated for cancer 
do not seem to be related to their objective fertility status but rather to the perception they have of their 
reproductive potential. This is in line with Leventhal’s Common Sense Model of Illness [70, 71] which suggests 
that it is not the objective characteristics of a particular illness but the way individuals conceptualise them that 
may affect the way they psychologically respond to illness. One of the concepts studied within the context of 
psycho-oncology, fear of cancer recurrence, showed a similar pattern. According to a recent review by Simard et 
al. [72], these fears do not seem to be associated with the objective characteristics of the disease such as cancer 
type, stage or treatment but rather with physical symptoms and various psychological factors. 
Since objectively defined fertility status does not seem to be related to psychological well-being as 
even women who underwent fertility sparing procedures present with psychological issues, fertility-related 
interventions may play an important role in comprehensive cancer care for young women. The second objective 
of this review was to look at such interventions and their influence on women’s psychological well-being. The 
scarce evidence from the literature points to beneficial effect of fertility-related interventions. Outcomes 
specifically related to decision making such as decisional regret and decisional conflict improved when patients 
were provided with the decision aid or counselled by a fertility specialist [34, 37]. Particularly for decision aids, 
evidence shows that they reduce decisional conflict related to the feelings of being uninformed or unsure about 
personal values that may affect the decision [73]. They also stimulate patients to be more active in their 
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treatment-related decision-making process [73]. Patients may not always be interested in independently deciding 
upon their treatment [74-76]; however, the literature shows that most of the time they want to be informed about 
their options [77-79]. This allows individuals to gain control over their life, promotes participation in treatment 
and increases compliance, reduces anxiety, and also creates realistic expectations about the future [80, 81]. Two 
systematic reviews targeting breast cancer survivors [26, 27] and one including women with variable chronic 
non-communicable diseases [25] explored their information needs concerning fertility and found that women 
wanted information about fertility; however only 34% to 72% across different studies reported having had a 
conversation about fertility with their physician. Especially women without children and those with a high 
desire for future children express the importance of fertility-related information since it might be a factor that 
plays a role in treatment decision-making [27]. 
Counselling, online support, and finally fertility preservation all seemed to have improved patients’ 
quality of life. Online interventions might be a promising way of delivering support especially to younger cancer 
survivors. The World Wide Web is a fast growing resource to which particularly younger people turn to in order 
to find information concerning their health [82, 83]. They also seek peer support via social media [84] or online 
forums [85]. Likewise, researchers have noticed the benefits of the Internet and a variety of interventions have 
been designed and delivered online for a range of cancer-related problems [86-90].  
Out of all the medical options, fertility preservation treatment not only empowers young women with 
knowledge conveyed during fertility consultation but also offers a real possibility of having children after the 
cessation of cancer treatment. As suggested by the American Society of Clinical Oncology [15, 16] as well as 
National Institute for Health and Care Excellence guidelines [91], all cancer patients in their reproductive years 
should be counselled concerning the effect of cancer on fertility and where possible, offered FP treatment. This 
is important since the qualitative evidence shows that patients value childbearing opportunity post-cancer 
because it gives them the sense of normality, reconnects them with peers and motivates them to look forward to 
the future [2-6]. Nonetheless, there exist several barriers to discussing fertility with young patients [18, 20, 92] 
which may in turn affect who gets referred to fertility specialists and undergoes FP.  
The third objective of this review was to look at the reproductive decisions in young female cancer 
survivors. Two studies that looked at predictors of the uptake of FP treatment [34, 37] indicated that several 
factors exist associated with pursuing FP, including younger age, desire for children, not having children, level 
of education, and also attitudes towards FP. Whether some of these factors emerged because of the way 
clinicians selected patients who should be referred to FP or whether effectively younger and childless women 
Manuscript Journal of Cancer Survivorship 
The final publication is available at Springer via http://dx.doi.org/10.1007/s11764-014-0388-9 
 
20 
 
are more likely to pursue FP remains unexplained. Some clinicians may be reluctant to refer their patients to FP 
treatment which results from their relative lack of knowledge and where to refer patients [20] as well as its 
relative novelty [93]. Nonetheless, other techniques can be used to spare fertility in cancer patients. Radical 
trachelectomy for cervical cancer is one of them. This is a choice for patients who were diagnosed with cancer 
in early stages. As the evidence suggests, young cervical cancer patients report a desire to preserve their fertility 
as a main reason to undergo this type of treatment [39, 38].  Fertility also seemed to affect decisions concerning 
chemotherapy for breast cancer with women who wanted to preserve their childbearing potential being less 
likely to accept chemotherapy [21].   
Surviving cancer diagnosis, avoiding cancer recurrence but also preserving one’s reproductive 
potential, is challenging. Often these decisions are made under substantial uncertainty regarding the outcome 
(more radical treatment that could impair fertility does not necessarily prevent recurrence nor guarantee higher 
odds of survival in carefully selected groups of patients [94]). According to the prospect theory [95], which 
describes making decisions under risk and uncertainty, the value of an outcome of a decision is not absolute. 
This theory purports that in the editing stage of the decision-making process one sets a reference value and the 
potential outcomes are coded as losses or gains relative to the reference point. Subsequently, in the evaluation 
phase, the probability of each possible outcome is assessed and these probabilities are weighed against the 
values. The decision is finally made based on the outcomes’ final utilities conceptualised as subjective values. 
Treadwell, Lenert [96] who applied the prospect theory to health values explain that changes in health states are 
relative to an individual baseline level of health. If this reference level, even in the context of cancer involves 
intact reproductive health and the subjective value attached to it is high, then a decision to undergo fertility 
sparing treatment might be a reasonable one. Similar reasoning might be applied to decisions about pregnancy 
after cancer treatment. If pregnancy and expanding one’s family is highly valued, the decision to conceive might 
be made despite factors that appear in the literature such as worries about child’s and mother’s health or fear of 
cancer recurrence [42, 50, 58, 62-64]. As mentioned earlier, pregnancy subsequent to cancer might be related to 
cancer survivors’ well-being. Adams et al. [23] in their review of qualitative literature focusing on experiences 
of young breast cancer survivors suggest that being able to achieve a pregnancy after cancer is part of the 
normalising process which allows women to continue with their everyday lives after diagnosis. In another 
review exploring attitudes towards childbearing among breast cancer survivors, Goncalves et al. [24] also point 
to beneficial effects of having children after cancer such as regaining hope about the future, being motivated to 
stay healthy and alive, and reconnecting with peers. On the other hand, Adams et al. [23], Goncalves et al. [24] , 
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and Peate et al. [27] underline that many women change their reproductive decisions and abandon their wish for 
children because of multiple fears they experience with regard to their own health and the health of future 
children. Yet, the medical literature suggests that pregnancy after breast does not increase mortality or the risk 
of cancer recurrence [97-99], nor does it result in foetal malformations [100, 101]. This needs to be brought to 
patients’ attention given that these are the most frequently mentioned factors that might influence decisions 
about conception post-cancer. As noted earlier, radical trachelectomy may indeed result in perinatal 
complications, however, with close obstetrical follow-up, a successful pregnancy is possible [69].  
On the whole, the results related to the third objective suggest that cancer can have mixed effect on 
childbearing subsequent to cancer. For the majority of the patients, there was no change in their desire for 
children; however, the minority that reported the decrease in their desire for children should not be neglected. It 
is especially important for the latter group that information about risks associated with reproduction post-cancer 
should be clearly presented in order for them to be able to make informed decisions about their fertility. 
Limitations 
The above conclusions should be interpreted accounting for both the limitations of the included studies 
as well as those of the review. 
In general, across all the included studies, several weaknesses have been identified. These include 
small sample sizes, homogeneity of participants within the studies and homogeneity of locations across the 
studies (with 21 studies having been conducted in the US, 2 in Australia and 1 in each of the following 
countries: France, Italy, United Kingdom, Israel and Saudi Arabia), predominantly cross sectional design, 
heterogeneity of outcome measures, and the lack of clear definition of fertility issues. The quality checklist [40] 
was used to assess the quality of each included study. The overall quality scores ranged from 44.4% to 100% 
(55.6% to 100% for studies related to objective 1; 68.2% to 90.9% for studies related to objective 2; 44.4% to 
100% for studies related to objective 3, and 61.6% to 90.9% for additional articles). The median quality scores 
for studies pertaining to objectives 1, 2, 3 and for additional studies were 86.4%, 77%, 81.85% and 72.7% 
respectively. This suggests that on the whole the quality of the included studies was acceptable; however, 
caution should be applied especially when considering the conclusions related to objective 1.  
Three studies pertaining to objective 1 that received the lowest scores: 55.6%, 60% and 66.7% [38, 43, 
45] all looked at the psychological well-being of cervical cancer patients and presented descriptive statistics 
based on very small sample sizes (20-33 participants). All of them defined fertility issues as the provision of 
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fertility sparing or compromising treatment. This might have introduced bias into our findings that when fertility 
issues are defined in an objective manner, they do not impact on well-being. However, four other studies of 
acceptable quality (>80%) which also conceptualised fertility in objective terms, continue to support our 
conclusions. 
Two of the above studies [38, 43] and two additional ones [61, 64] that scored 44.4% and 65% 
respectively, were included in the summary of the results for objective 3. These results were to a certain extent 
balanced by the remaining 14 studies of satisfactory quality (>70%) that pertained to objective 3. 
Although the quality of the studies related to objective 2 was generally good, the small number of 
studies (n=4) prevents from drawing firm conclusions. 
The number of participants ranged from 20 to 1088 (median 71) across studies related to objective 1, 
from 29 to 1041 (median 106) across studies related to objective 2 and from 20 to 1088 (median 102) across 
studies related to objective 3. Given the large numbers of predictors and outcomes looked at in most of the 
studies, there exists a possibility they might have been underpowered to detect significant associations or 
changes in outcomes. Additionally, the vast majority of the studies did not provide the information about the 
estimated sample size needed to power the calculations. This might have biased the results of the individual 
studies and thus the conclusions of this review. 
The samples in most of the studies consisted of well-educated, predominantly white women with 
relatively high income, which is an issue in this type of research in general. Also, the majority of the studies 
(81.2%, 75%, 72.2% and 80% for objectives 1, 2, 3 and additional studies, respectively) were conducted in the 
United States. This undermines the generalizability of the conclusions of this review, especially since the 
problems with fertility and attitudes towards parenting are strongly dependent on socio-cultural norms [102]. 
The majority of the studies pertaining to objectives 1 and 3 (63.6% and 66.7%, respectively) used 
cross-sectional design. This allows drawing conclusions about associations between fertility issues and well-
being; however, makes the inferences about causality problematic. For objective 2, three studies were 
interventions while one used the exposure study methodology [34]. The latter had the biggest sample size 
(n=918) and also looked at many outcomes of interest, which given the overall small number of studies, might 
have influenced the conclusions. 
The heterogeneity of outcome measures made comparing the results of individual studies problematic, 
since different instruments, even when measuring the same constructs, might have been based on slightly 
different definitions of these constructs (e.g. the quality of life).    
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Finally, the definitions of fertility issues differed between the studies. Even within the categories that 
were adopted for the purpose of this review (see Review objectives), the definitions were not homogenous. 
Some of the studies made the definition explicit, while others did not provide the definition at all [42]. This 
means that we cannot be sure if the results included in this review all tapped into the same construct of fertility 
issues. 
Also, this review only looked at the published literature that was searched via electronic databases. 
This means that due to publication bias, we might have failed to include studies presenting insignificant results. 
The exclusion of the articles written in non-English languages might have additionally contributed to the 
omission of relevant papers and thus introduced bias. However, only 4% of all the articles judged as potentially 
relevant based on their title were published in a language other than English. Finally, we have not looked at how 
different healthcare systems across the countries where the studies have been conducted, could potentially 
influence our findings. Treatment-related decisions, especially pursuing FP can effectively be constrained in the 
countries where FP is not covered by the health insurance. The studies included in this review that examined the 
decisions about FP did not specifically investigate costs as a barrier to pursuing FP. In the study by Letourneau 
et al. [35], income was not related to pursuing fertility preservation, however more research explicitly analysing 
how costs can influence FP-related decisions is needed. 
Conclusions 
This review highlights the importance of fertility issues in a population of younger cancer survivors. 
Overall the evidence suggests that: 
 Perception of one’s own reproductive potential might be more powerful in affecting women’s 
psychological well-being than the objective fertility status. 
 Empowering women with knowledge concerning their fertility after cancer seems to have beneficial 
effects on their QoL and decision-specific outcomes. Offering fertility preservation to young cancer 
patients is an important part of the comprehensive cancer care. 
 Cancer can have mixed effect on reproductive decisions in young female cancer survivors. Factors that 
affected women’s decisions encompassed mostly medical concerns about the offspring’s and mother’s 
health. Yet the evidence from the medical research does not seem to warrant such fears. 
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The above conclusions should, however, be treated with caution due to multiple limitations of the 
studies included in the review as well as the limitations of the review itself. 
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